Stereoselective synthesis of (E)-4-(imidazo[1,2-a]pyrid-2-yl)-3-(4-methylphenylsulfonyl)but-3-en-2-one. X-ray crystal structure and conformational analysis
-
Add time:08/27/2019 Source:sciencedirect.com
The title compound, gem-ketovinylsulfone 3, was obtained stereoselectively (de > 98%) by the action of the α-anion from p-tolylsulfonylacetone 1 on imidazol[1,2-a]pyridine-2-carbaldehyde 2 in chelation-controlled conditions in the presence of a Lewis acid (ZnCl2). The X-ray crystal structure of 3 [C18H16N2O3S: Mt = 340.4, orthorhombic, Pbca, a = 12.208(3) Å, b = 18.848(4) Å, c = 14.566(11)Å, V = 3.351(3) Å3, Z = 8, Dcalc = 1.349 g cm−3, λ(CuKα) = 1.54178Å, μ = 1.83 mm−1, F(000) = 1424, T = 293 K, R = 0.061 for 2.046 observed reflections] was determined, and confirmed the (E) configuration. Despite the conjugate position of the vinyl double bond, quasi-coplanar with the imidazopyridine heterocycle, there is no evidence of p-electron delocalization. The crystal cohesion is ensured by a dense network of van der Waals contacts. The conformational analysis of the (E) and (Z) stereoisomers was performed by molecular dynamics simulation, and showed the (E) isomer to be 9.1 kJ mol−1 more stable than the (Z) isomer.
We also recommend Trading Suppliers and Manufacturers of 1-(4-METHYLPHENYLSULFONYL)-1,2,4-TRIAZOLE (cas 13578-51-3). Pls Click Website Link as below: cas 13578-51-3 suppliers
Prev:Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenylurea) (LY181984) modulated by redox
Next:Research paperInvestigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperInvestigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors08/28/2019
- Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenylurea) (LY181984) modulated by redox08/26/2019
- Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives08/25/2019
- Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) and response to epidermal growth factor08/24/2019
- A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984)08/23/2019
- Research paperProton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N′-(4-cholorophenyl) urea (LY181984)08/22/2019
- Regular paperNADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY 181984) at an external site08/21/2019
- Regular paperThe antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes08/20/2019
- Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)-urea08/19/2019
-
Health and Chemical more >
-
Related Products


